Fischer M - Search Results

1

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.

Alborzinia H, Flórez AF, Kreth S, Brückner LM, Yildiz U, Gartlgruber M, Odoni DI, Poschet G, Garbowicz K, Shao C, Klein C, Meier J, Zeisberger P, Nadler-Holly M, Ziehm M, Paul F, Burhenne J, Bell E, Shaikhkarami M, Würth R, Stainczyk SA, Wecht EM, Kreth J, Büttner M, Ishaque N, Schlesner M, Nicke B, Stresemann C, Llamazares-Prada M, Reiling JH, Fischer M, Amit I, Selbach M, Herrmann C, Wölfl S, Henrich KO, Höfer T, Trumpp A, Westermann F. Alborzinia H, et al. Among authors: fischer m. Nat Cancer. 2022 Apr;3(4):471-485. doi: 10.1038/s43018-022-00355-4. Epub 2022 Apr 28. Nat Cancer. 2022. PMID: 35484422 Free PMC article.

2

Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.

Oberthuer A, Skowron M, Spitz R, Kahlert Y, Westermann F, Mehler K, Berthold F, Fischer M. Oberthuer A, et al. Among authors: fischer m. Gene. 2005 Dec 19;363:41-50. doi: 10.1016/j.gene.2005.07.038. Epub 2005 Oct 10. Gene. 2005. PMID: 16216448

3

Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.

Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B, Oberthuer A, Berthold F, Wei JS, Khan J, Schwab M, Westermann F. Henrich KO, et al. Among authors: fischer m. Clin Cancer Res. 2006 Jan 1;12(1):131-8. doi: 10.1158/1078-0432.CCR-05-1431. Clin Cancer Res. 2006. PMID: 16397034

4

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

Oberthuer A, Warnat P, Kahlert Y, Westermann F, Spitz R, Brors B, Hero B, Eils R, Schwab M, Berthold F, Fischer M. Oberthuer A, et al. Among authors: fischer m. Cancer Lett. 2007 Jun 8;250(2):250-67. doi: 10.1016/j.canlet.2006.10.016. Epub 2006 Nov 28. Cancer Lett. 2007. PMID: 17126996

5

Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.

Warnat P, Oberthuer A, Fischer M, Westermann F, Eils R, Brors B. Warnat P, et al. Among authors: fischer m. BMC Cancer. 2007 May 25;7:89. doi: 10.1186/1471-2407-7-89. BMC Cancer. 2007. PMID: 17531100 Free PMC article. Review.

6

High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.

Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M. Westermann F, et al. Among authors: fischer m. Clin Cancer Res. 2007 Aug 15;13(16):4695-703. doi: 10.1158/1078-0432.CCR-06-2818. Epub 2007 Jul 25. Clin Cancer Res. 2007. PMID: 17652624

7

Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.

Nowacki S, Skowron M, Oberthuer A, Fagin A, Voth H, Brors B, Westermann F, Eggert A, Hero B, Berthold F, Fischer M. Nowacki S, et al. Among authors: fischer m. Oncogene. 2008 May 22;27(23):3329-38. doi: 10.1038/sj.onc.1210996. Epub 2007 Dec 17. Oncogene. 2008. PMID: 18084322

8

Risk estimation of neuroblastoma patients using molecular markers.

Fischer M, Spitz R, Oberthür A, Westermann F, Berthold F. Fischer M, et al. Klin Padiatr. 2008 May-Jun;220(3):137-46. doi: 10.1055/s-2008-1065345. Klin Padiatr. 2008. PMID: 18478485 Review.

9

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.

Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M. Westermann F, et al. Among authors: fischer m. Genome Biol. 2008 Oct 13;9(10):R150. doi: 10.1186/gb-2008-9-10-r150. Genome Biol. 2008. PMID: 18851746 Free PMC article.

10

Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.

Oberthuer A, Kaderali L, Kahlert Y, Hero B, Westermann F, Berthold F, Brors B, Eils R, Fischer M. Oberthuer A, et al. Among authors: fischer m. Clin Cancer Res. 2008 Oct 15;14(20):6590-601. doi: 10.1158/1078-0432.CCR-07-4377. Clin Cancer Res. 2008. PMID: 18927300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,075 results

Search Page